Cipla | CIPLA - Операционный доход





Операционный доход Изменить Дата
Arca Biopharma USD -34.43M 326K 2025-12
aTyr Pharma USD -128K 24.6M 2026-03
Bio Path USD -488K 4.07M 2025-09
Brainstorm Cell Therapeutics USD -2.24M 197K 2025-12
Capricor Therapeutics USD -29.16M 2.87M 2025-12
Cara Therapeutics USD -5.94M 3.55M 2025-09
Cipla INR 8.88B 2.74B 2026-06
Dr.Reddys Laboratories INR 3.25B 2.36B 2026-06
Immunic USD -23.33M 2.67M 2025-12
Minerva Neurosciences USD -21.85M 17.48M 2024-12
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sun Pharmaceuticals INR 35.57B 8.05B 2026-06
TherapeuticsMD USD -1.18M 40K 2024-06
UPL INR 27.32B 11.26B 2026-03